Recurrent Testicular Cancer


Spread the Word! April is Testicular Cancer Awareness Month (April 8, 2016)

As the month of April brings testicular cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment options,... Continue Reading

National Testicular Cancer Awareness Month on CancerConnect (April 7, 2015)

Sun Valley, ID & Fort Worth, TX– OMNI Health Media (OMNI) announces the launch of testicular cancer educational programs for national testicular cancer awareness month. As the month of April... Continue Reading

Testicular Cancer Rates on the Rise (June 24, 2013)

The incidence of testicular cancer continued to rise in the United States over the past decade, most notably among Hispanic men, according to the results of a study presented at the annual meeting of the... Continue Reading

Coping with Taste Changes (June 4, 2012)

If you’re undergoing chemotherapy, biologic therapy, or radiation to the head or neck area, one of the side effects you may experience is a change in how things taste. While this may seem like a minor... Continue Reading

Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)

Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according... Continue Reading

Paclitaxel/Gemzar Provides Long-Term Survival in Refractory Testicular Cancer (June 14, 2011)

Treatment with the chemotherapy agents paclitaxel and Gemzar® (gemcitabine) provides long-term survival and possible cure among some patients with testicular cancer that has stopped responding to prior... Continue Reading

Recurrent Testicular Cancer Potentially Curable with High-dose Therapy and Stem Cell Transplant (July 26, 2007)

Recurrent Testicular Cancer Potentially Curable with High-dose Therapy and Stem Cell Transplant According to an article recently published in the New England Journal of Medicine, metastatic testicular... Continue Reading

Surgery Linked with Good Outcomes for Patients with Late Relapse of Metastatic Testicular Cancer (August 25, 2006)

Surgery Linked with Good Outcomes for Patients with Late Relapse of Metastatic Testicular Cancer Patients who experience a cancer relapse more than two years after treatment for metastatic nonseminomatous... Continue Reading

Survivors of Testicular Cancer May Have Increased Risk of Cardiovascular Disease (January 19, 2006)

Survivors of Testicular Cancer May Have Increased Risk of Cardiovascular Disease According to a recent article published in the Journal of Clinical Oncology, men who have survived testicular cancer may... Continue Reading

Ifosfamide/Paclitaxel/Cisplatin Highly Effective for Recurrent Testicular Cancer (September 22, 2005)

Ifosfamide/Paclitaxel/Cisplatin Highly Effective for Recurrent Testicular Cancer According to results recently published in the Journal of Clinical Oncology, the chemotherapy combination of ifosfamide... Continue Reading

Stem Cell Transplantation Cures Many Patients with Recurrent Testicular Cancer (February 26, 2002)

Stem Cell Transplantation Cures Many Patients with Recurrent Testicular Cancer While the majority of patients with testicular cancer are cured following standard therapy, some patients experience... Continue Reading

High-dose chemotherapy and stem cell support: a promising therapy for patients with germ cell cancers who have failed chemotherapy. (February 26, 2002)

High-dose chemotherapy and stem cell support: a promising therapy for patients with germ cell cancers who have failed chemotherapy. Treatment of patients with testicular germ cell cancer or non-gonadal... Continue Reading

Maintenance chemotherapy with daily oral etoposide was effective in patients receiving salvage therapy for germ cell tumors. (February 26, 2002)

Maintenance chemotherapy with daily oral etoposide was effective in patients receiving salvage therapy for germ cell tumors. Treatment of patients with metastatic testicular cancer who have failed... Continue Reading

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS